Disposition of 6124 shares by Ryan Martins of 89bio at 11.53 subject to Rule 16b-3
| ETNB Stock | USD 9.64 0.91 10.42% |
About 54% of 89bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding 89bio Inc suggests that some traders are interested. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
89bio |
Filed transaction by 89bio Inc Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
89bio Fundamental Analysis
We analyze 89bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
89bio is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
89bio Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 89bio stock to make a market-neutral strategy. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics with similar companies.
Peers
89bio Related Equities
| HEPA | Hepion Pharmaceuticals | 5.56 | ||||
| ACLX | Arcellx | 4.65 | ||||
| STOK | Stoke Therapeutics | 4.57 | ||||
| MDGL | Madrigal Pharmaceuticals | 3.67 | ||||
| INZY | Inozyme Pharma | 2.82 | ||||
| AKRO | Akero Therapeutics | 2.52 | ||||
| MREO | Mereo BioPharma | 2.09 | ||||
| VKTX | Viking Therapeutics | 0.78 | ||||
| HOOK | Hookipa Pharma | 0.50 | ||||
| TGTX | TG Therapeutics | 0.03 | ||||
| ABOS | Acumen Pharmaceuticals | 0.64 | ||||
| PLRX | Pliant Therapeutics | 0.74 | ||||
| DAWN | Day One | 1.51 | ||||
| TERN | Terns Pharmaceuticals | 6.28 | ||||
| XFOR | X4 Pharmaceuticals | 10.81 |
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |